The global cancer immunotherapy market is accounted for $45,471 million in 2015, and is estimated to reach $117,114 million by 2022, growing at a CAGR of 14.5% during the analysis period of 2016-2022. Cancer Immunotherapy is a method of cancer treatment that boosts the immune system in fighting cancer. This therapy is more advantageous than the traditional approach as it delivers long-term protection against cancer, has minimal side effects, and avails treatment to more cancer types. Immunotherapy works by guiding system toward cancer-specific targets, followed by activation of immune system to mobilize the target, and produces response that can eradicate cancer targeted cells. There are many factors, such as increase in incidence of cancer, rise in healthcare expenditure, increased access to medical insurance, and technological advancements in cancer treatment therapies that fuel the growth of the global cancer immunotherapy market. However, the factors such as lack of awareness about cancer immunotherapy are anticipated to inhibit the growth of the market. Also, the high product developmental cost is expected to impede the growth of the market.
Get Sample Report @ https://goo.gl/i4Q9in
The market is segmented based on technology, application, end-users, and geography. By technology, this market is categorized into monoclonal antibodies, cytokines & immunomodulators, and other technologies. By application, it is classified into lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and other applications. By end-users, it is divided into hospitals, cancer research centers, and clinics. Geographically, it is studied across North America, Europe, Asia Pacific, and LAMEA.
KEY MARKET BENEFITS:
- Comprehensive analysis of factors that drive and restrict the growth of the global cancer immunotherapy market is provided.
- The projections in the market are made by studying the current market trends and future market potential for the period (2014-2022) in terms of value.
- Extensive analysis by technology and application helps understand the various trends and prevailing opportunities in the respective market
- Key market players within the global cancer immunotherapy market are profiled in the market and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global cancer immunotherapy market.
List of players profiled in the report
- F. Hoffmann-La Roche AG.
- Advaxis Inc.
- Merck & Co., Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Novartis AG
- Bayer AG
Enquire More About Report @ https://goo.gl/UCdMxZ
Table of Content
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET SHARE ANALYSIS OF CANCER IMMUNOTHERAPY MARKET, 2015
CHAPTER 4 CANCER IMMUNOTHERAPY MARKET, BY TECHNOLOGY
4.2. MONOCLONAL ANTIBODIES
CHAPTER 5 CANCER IMMUNOTHERAPY MARKET, BY APPLICATION
5.2. LUNG CANCER
5.3. BREAST CANCER
5.4. COLORECTAL CANCER
To Read the Complete Report with TOC Visit @ https://goo.gl/hZm3ST
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Toll Free : +1 (800) 910-6452